Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases
- 11 September 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 90 (11) , 1354-1360
- https://doi.org/10.1002/bjs.4325
Abstract
Background In a significant proportion of women with breast cancer, the sentinel node is the only involved node in the axilla. The purpose of this study was to identify factors associated with histologically positive non-sentinel lymph nodes. Methods Between 1997 and 2002, 800 women with early breast cancer underwent sentinel node biopsy. In 263 patients the node contained metastases, including 83 with micrometastases detected by immunohistochemistry (IHC), 40 micrometastases detected on haematoxylin, eosin and safranine (HES) staining, and 140 macrometastases. All clinical and histological criteria were recorded and analysed with reference to histology of the non-sentinel node. Results The risk of metastasis in the non-sentinel lymph node was related to the volume of the tumour in the sentinel node. Non-sentinel nodes were involved in five (6·0 per cent) of 83 women when the sentinel node contained only micrometastatic cells detected on IHC, and in three (7·5 per cent) of 40 women when micrometastases were detected by HES, compared with 55 (39·3 per cent) of 140 when the sentinel node contained macrometastases on HES staining. Univariate analysis revealed a significant association between non-sentinel node involvement and type of metastasis within the sentinel node, clinical primary tumour size, palpable axillary lymph nodes before operation, pathological primary tumour size and the presence of peritumoral lymphovascular invasion. On multivariate analysis, the type of metastasis within the sentinel node (P < 0·001), histological tumour size greater than 20 mm (P = 0·017) and the presence of palpable axillary nodes before operation (P = 0·014) remained significant. Conclusion Clinical and pathological factors associated with sentinel node histology can reliably predict women for whom further axillary clearance is recommended, but it is not yet possible to determine a subgroup of patients in whom the sentinel node is the only involved node and for whom further axillary treatment may be unnecessary.Keywords
This publication has 30 references indexed in Scilit:
- Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancerBritish Journal of Surgery, 2002
- Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily PracticeLaboratory Investigation, 2002
- Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, PennsylvaniaCancer, 2002
- Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axillaEuropean Journal of Surgical Oncology, 2001
- Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patientsEuropean Journal of Surgical Oncology, 2001
- Technical details for the sentinel node biopsy in breast cancer: a guide for the training processEuropean Journal of Surgical Oncology, 2001
- Sentinel Lymph Node Detection for Breast Cancer: Which Patients Are Best Suited for the Patent Blue Dye Only Method of Identification?Annals of Surgical Oncology, 2001
- Do All Patients With Sentinel Node Metastasis From Breast Carcinoma Need Complete Axillary Node Dissection?Annals of Surgery, 1999
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Axillary dissection of level I and II lymph nodes is important in breast cancer classificationEuropean Journal Of Cancer, 1992